Magante, Nieva T.

HRN: 16-84-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
LEVOFLOXACIN 500MG (TAB)
06/10/2022
06/17/2022
PO
500 Mg
Od
Acute Pyelonephritis
Waiting Final Action 

Indication:  EmpiricEmpirical De-escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: